Repare Therapeutics Inc.
Develops precision oncology drugs using a CRISPR platform for cancers with genomic instabilities.
RPTX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US7602731025
- LEI:
- Country:
- United States of America
- Address:
- 7171 FREDERICK BANTING, SAINT-LAURENT
- Website:
- https://www.reparerx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Repare Therapeutics Inc. is a clinical-stage precision oncology company that discovers and develops novel cancer therapies. The company's core strategy is based on synthetic lethality, a concept where combinations of genetic mutations lead to cell death. Repare utilizes its proprietary, genome-wide, CRISPR-enabled SNIPRx® platform to systematically identify and validate new therapeutic targets. Its pipeline focuses on developing highly targeted, small molecule drugs designed to treat cancers with specific genomic instabilities, particularly those related to DNA damage repair, addressing patient populations with high unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Repare Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Repare Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Repare Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
